Figure 1.
Figure 1. NCTN (alliance-led) and BMT-CTN postautograft phase II trial of ibrutinib for relapsed/refractory ABC NHL.

NCTN (alliance-led) and BMT-CTN postautograft phase II trial of ibrutinib for relapsed/refractory ABC NHL.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal